Skip to main content

ExodusPoint Capital Management, LP

Position in ABT — Abbott Laboratories

CIK 1736225 NEW YORK, NY

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,965,611
-$459,349 QoQ
Shares Held
109,826
+20.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#477
of 2,905 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Sep 30, 2020
CallValue
$6,790,992
CallShares
62,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $464,643,980 across 33 Medical Devices names. ABT ranks #6 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ABT
Abbott Laboratories
This page
109,826 $9,965,611

All Filings in ABT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,965,611 109,826
2024-09-30 $10,424,960 91,439
2024-06-30 $8,563,430 82,412
2024-03-31 $4,730,642 41,621
2023-09-30 $5,734,294 59,208
2023-03-31 $18,858,358 186,237
2022-12-31 $1,941,526 17,684
2022-09-30 $2,846,001 29,413
2022-06-30 $25,365,863 233,464
2022-03-31 $21,709,709 183,421
2021-09-30 $8,187,708 69,311
2021-03-31 $4,726,849 39,443
2020-12-31 $10,214,650 93,293
2020-09-30 $14,944,862 137,323
2020-09-30 $6,790,992 62,400
2020-06-30 $2,412,289 26,384